ENDO Online 2020 — the Endocrine Society’s largest-ever meeting — will open with a panel discussion exploring the COVID-19 pandemic’s impact on the endocrinology field.
The virtual meeting will run from June 8-22 and feature both on-demand and live content. More than 19,000 attendees have registered for the event.
“COVID-19 is altering many aspects of our work as endocrine clinicians and researchers,” said session co-chair John Newell-Price, MA, PhD, FRCP, chair of Endocrinology and Honorary Consultant Physician, The University of Sheffield, U.K.. “By pooling our knowledge and expertise, we can ensure our patients receive the best possible care during the pandemic.”
The live panel session, “Endocrinology in the Age of COVID-19,” will feature three international speakers sharing their perspectives on how the pandemic is affecting patient care. The panel will discuss mitigating COVID-19 risks for individuals with diabetes and obesity, best practices for managing individuals with COVID-19 and diabetes, and how the disease affects individuals with adrenal insufficiency.
The speakers include:
- Manuel Puig-Domingo, MD, PhD, Hospital Universitari Germans Trias in Pujol, Spain
- Endocrine Reviews editor-in-chief Daniel J. Drucker, MD, of Mount Sinai Hospital in Toronto, Canada
- Wiebke Arlt, MD, DSc, FRCP, F.Med.Sci., of the University of Birmingham, U.K.
The panel will be moderated by the session’s co-chairs — Newell-Price and Andrea Giustina, MD, professor and chair of Endocrinology and Metabolism and director, Postgraduate School of Endocrinology and Metabolic Diseases at San Raffaele Vita-Salute University in Milan, Italy. The session will be held June 8 at 10 a.m. Eastern. ENDO Online 2020 attendees will be able to ask questions live via chat.
The session was developed in collaboration with the European Society of Endocrinology.
ENDO Online 2020 will feature an entire day dedicated to basic science sessions on reproduction, diabetes and obesity, nuclear receptor biology, and pituitary and adrenal physiology, among other topics. Donald P. McDonnell, PhD, whose nuclear receptor ligands research spurred the development of a new generation of drugs for the treatment of hormone-dependent cancers and metabolic disease, will be delivering the keynote on June 9.
The ENDO Online 2020 schedule is available online.
The Society is offering complimentary registration for this year’s event to support those affected by COVID-19.